Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
about
CYB5A polymorphism increases androgens and reduces risk of rheumatoid arthritis in women.Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritisRenal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus.Low levels of dehydroepiandrosterone sulphate in plasma, and reduced sympathoadrenal response to hypoglycaemia in premenopausal women with rheumatoid arthritis.The multiple facets of premature aging in rheumatoid arthritis.Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis.Nonpeptide corticotropin-releasing hormone receptor type 1 antagonists and their applications in psychosomatic disorders.Integrated neuroendocrine immune risk factors in relation to rheumatoid arthritis: should rheumatologists now adopt a model of a multiyear, presymptomatic phase?Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-α blocking etanercept treatmentDialogue between the brain and the immune system in inflammatory arthritis.The immuno-endocrine component in the pathogenesis of tuberculosis.Impaired hypothalamo-pituitary-adrenal axis in patients with ankylosing spondylitis.The brain and immune system prompt energy shortage in chronic inflammation and ageing.Role of 11β-HSD type 1 in abnormal HPA axis activity during immune-mediated arthritis.Metabolic syndrome in Chinese patients with systemic lupus erythematosus: no association with plasma cortisol level.Neuroendocrine Immune System Involvement in Rheumatology
P2860
Q35212919-65DEFA39-E9A5-42A1-B621-DD3B9C5ED04EQ35554324-F3545BC4-2907-4D2B-B16A-A77911AAE912Q35554437-F2F8AE59-B8D5-401B-98BD-4CCEF75957EBQ35555163-512C2B9C-96BC-49FB-9525-987BF431D0E1Q35559238-EC8B287A-E90B-4B84-87CB-083F1BAD43F4Q35638187-44450AC9-ACE9-4C91-8A43-CB875B4535E4Q35937847-B8D5399E-E59C-4A0C-ABEC-E79F6A7929D1Q36290139-921FB70F-61D9-4654-A3A7-561B49C7107CQ36633403-98BE06E5-5D55-407E-A877-996CC6B785DBQ36693958-F808DD2E-8286-43DB-84B6-53E258B30AA8Q36884501-0136FDED-B652-42D8-8DB5-20C6CC3E0AF1Q42457220-2486CF8A-5061-4A0B-9BE3-F0BAA0279362Q47600160-ED4E430E-137C-476D-83A8-46151420D266Q47828271-AA95FAEB-7CD3-479D-AF8E-E1CF936A46EFQ50861922-7E2EAEAF-CAFC-4A50-8F92-F5558A639358Q58042996-E4AE8A9F-93C3-4A64-A77B-09E0C5E4913D
P2860
Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Long-term anti-tumor necrosis ...... rs adrenal androgen secretion.
@en
Long-term anti-tumor necrosis ...... rs adrenal androgen secretion.
@nl
type
label
Long-term anti-tumor necrosis ...... rs adrenal androgen secretion.
@en
Long-term anti-tumor necrosis ...... rs adrenal androgen secretion.
@nl
prefLabel
Long-term anti-tumor necrosis ...... rs adrenal androgen secretion.
@en
Long-term anti-tumor necrosis ...... rs adrenal androgen secretion.
@nl
P2093
P2860
P356
P1476
Long-term anti-tumor necrosis ...... rs adrenal androgen secretion.
@en
P2093
Christian Antoni
Frieder Kees
Georg Pongratz
Hanns-Martin Lorenz
Joachim R Kalden
Thomas F Schaible
P2860
P304
P356
10.1002/ART.11036
P577
2003-06-01T00:00:00Z